Abingdon Health (ABDX)

Sector:

Health Care

Index:

FTSE AIM All-Share

37.00p
   
  • Change Today:
    -0.50p
  • 52 Week High: 126.00
  • 52 Week Low: 27.50
  • Currency: UK Pounds
  • Shares Issued: 95.70m
  • Volume: 157,315
  • Market Cap: £35.41m

Abingdon Health inks sales and distribution agreement with BioSure UK

By Iain Gilbert

Date: Wednesday 10 Mar 2021

LONDON (ShareCast) - (Sharecast News) - Rapid tests developer Abingdon Health has signed a non-exclusive sales and distribution agreement in the UK and Europe for its AbC-19 rapid neutralising antibody test with BioSure UK.

Abingdon said on Wednesday that it will establish a strategic distribution relationship with BioSure to enable both firms to identify and maximise opportunities for the sale of the AbC-19 rapid neutralising antibody test in the UK and European territories.

The AIM-listed group stated healthcare, workplace and pharmacy settings will be prioritised, with antibody testing becoming "even more relevant" as vaccination programmes scale.

Chief executive Chris Yates said: "The nature of SARS-CoV-2 testing is changing. Where antibody tests were once predominantly used for charting the spread of infection within communities, today they emerging as a key pillar of large-scale immunisation campaigns.

"Rapid Antibody tests such as AbC-19 that target the full trimeric spike can help policymakers and healthcare networks further understand immunity to Covid-19 and the effectiveness of vaccine programmes."

As of 1050 GMT, Abingdon shares had shot up 7.40% to 103.64p.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

ABDX Market Data

Currency UK Pounds
Share Price 37.00p
Change Today -0.50p
% Change -1.33 %
52 Week High 126.00
52 Week Low 27.50
Volume 157,315
Shares Issued 95.70m
Market Cap £35.41m

ABDX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value Not Available
Price Trend
74.22% below the market average74.22% below the market average74.22% below the market average74.22% below the market average74.22% below the market average
80.49% below the sector average80.49% below the sector average80.49% below the sector average80.49% below the sector average80.49% below the sector average
Income Not Available
Growth Not Available

ABDX Dividends

No dividends found

Trades for 21-Sep-2021

Time Volume / Share Price
16:22 2,000 @ 36.90p
16:22 1,200 @ 36.10p
14:43 53 @ 36.10p
14:26 1,227 @ 36.35p
14:19 1,333 @ 36.90p

ABDX Key Personnel

CEO Chris Henry Francis Yates
CFO Melanie Ross

Top of Page